Advances in Dermatology and Allergology
facebook
eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current Issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Ethical standards and procedures Reviewers Instructions for authors Publication charge
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
2/2026
vol. 43
 
Share:
Share:
Original paper

Shared molecular mechanisms of vascular endothelial cells in psoriasis and diabetes comorbidity

Jiaxin Xu
1
,
Xin Zhang
1
,
Tianyuan Zhang
1
,
Gang Wang
1
,
Qingyang Li
1

  1. Department of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi’an, Shaanxi, China
Adv Dermatol Allergol 2026; XLIII (2): 191–202
Online publish date: 2026/04/13
Article file
- Shared molecular.pdf  [1.63 MB]
Get citation
 
 
1. Trimm E, Red-Horse K. Vascular endothelial cell development and diversity. Nat Rev Cardiol 2023; 20: 197-210.
2. Ager A. High endothelial venules and other blood vessels: critical regulators of lymphoid organ development and function. Front Immunol 2017; 8: 45.
3. Carman CV, Martinelli R. T lymphocyte-endothelial interactions: emerging understanding of trafficking and antigen-specific immunity. Front Immunol 2015; 6: 603.
4. Amersfoort J, Eelen G, Carmeliet P. Immunomodulation by endothelial cells – partnering up with the immune system? Nat Rev Immunol 2022; 22: 576-88.
5. Whiteford JR, De Rossi G, Woodfin A. Mutually supportive mechanisms of inflammation and vascular remodeling. Int Rev Cell Mol Biol 2016; 326: 201-78.
6. Parisi R, Iskandar IYK, Kontopantelis E, et al. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ 2020; 369: m1590.
7. Chen J, Zhu Z, Li Q, et al. Neutrophils enhance cutaneous vascular dilation and permeability to aggravate psoriasis by releasing matrix metallopeptidase 9. J Invest Dermatol 2021; 141: 787-99.
8. Zhu Z, Chen J, Lin Y, et al. Aryl hydrocarbon receptor in cutaneous vascular endothelial cells restricts psoriasis development by negatively regulating neutrophil recruitment. J Invest Dermatol 2020; 140: 1233-43.e9.
9. Li Q, Shao S, Zhu Z, et al. An IGFBP7hi endothelial cell subset drives T cell extravasation in psoriasis via endothelial glycocalyx degradation. J Clin Investig 2023; 133: e160451.
10. American Diabetes Association Professional Practice Committee. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2024. Diabetes Care 2024; 47: S20-42.
11. Shi Y, Vanhoutte PM. Macro- and microvascular endothelial dysfunction in diabetes. J Diabetes 2017; 9: 434-49.
12. Takeshita J, Grewal S, Langan SM, et al. Psoriasis and comorbid diseases: epidemiology. J Am Acad Dermatol 2017; 76: 377-90.
13. Armstrong AW, Guérin A, Sundaram M, et al. Psoriasis and risk of diabetes-associated microvascular and macrovascular complications. J Am Acad Dermatol 2015; 72: 968-77.e2.
14. Butler A, Hoffman P, Smibert P, et al. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol 2018; 36: 411-20.
15. Korsunsky I, Millard N, Fan J, et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods 2019; 16: 1289-96.
16. Li Q, Zhu Z, Wang L, et al. Single-cell transcriptome profiling reveals vascular endothelial cell heterogeneity in human skin. Theranostics 2021; 11: 6461-76.
17. Wu T, Hu E, Xu S, et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation 2021; 2: 100141.
18. Morabito S, Reese F, Rahimzadeh N, et al. hdWGCNA identifies co-expression networks in high-dimensional transcriptomics data. Cell Rep Methods 2023; 3: 100498.
19. Szklarczyk D, Franceschini A, Wyder S, et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res 2015; 43: D447-52.
20. Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003; 13: 2498-504.
21. Albareda M, Ravella A, Castelló M, et al. Metabolic syndrome and its components in patients with psoriasis. Springerplus 2014; 3: 612.
22. Li JP, Qiu S, Tai GJ, et al. NLRP3 inflammasome-modulated angiogenic function of EPC via PI3K/ Akt/mTOR pathway in diabetic myocardial infarction. Cardiovasc Diabetol 2025; 24: 6.
23. Shen F, Hu Z, Goswami J, et al. Identification of common transcriptional regulatory elements in interleukin-17 target genes. J Biol Chem 2006; 281: 24138-48.
24. Amado-Azevedo J, van Stalborch A-MD, Valent ET, et al. Depletion of Arg/Abl2 improves endothelial cell adhesion and prevents vascular leak during inflammation. Angiogenesis 2021; 24: 677-93.
25. Chen X, Qian J, Liang S, et al. Hyperglycemia activates FGFR1 via TLR4/c-Src pathway to induce inflammatory cardiomyopathy in diabetes. Acta Pharm Sin B 2024; 14: 1693-710.
26. Qiao H, Liu Y, Veach RA, et al. The adaptor CRADD/RAIDD controls activation of endothelial cells by proinflammatory stimuli. J Biol Chem 2014; 289: 21973-83.
27. Wesdorp M, Murillo-Cuesta S, Peters T, et al. MPZL2, encoding the epithelial junctional protein myelin protein zero-like 2, is essential for hearing in man and mouse. Am J Hum Genet 2018; 103: 74-88.
28. Ye H, Wang R, Wei J, et al. HADH may be the target molecule of early vascular endothelial impairment in T2DM. Front Cardiovasc Med 2022; 9: 963916.
29. Kim D, Shin J, Choi YK, et al. Targeting SLC25A33 suppresses vascular smooth muscle cell proliferation and migration by reducing cytosolic mtDNA levels: implications for occlusive vascular diseases. Diabetes Metab J 2026; 50: 139-52.
30. Zhang P, Lu J, Jing Y, et al. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis. Ann Med 2017; 49: 106-16.
31. Vegfors J, Ekman AK, Stoll SW, et al. Psoriasin (S100A7) promotes stress-induced angiogenesis. Br J Dermatol 2016; 175: 1263-73.
32. Shubbar E, Vegfors J, Carlström M, et al. Psoriasin (S100A7) increases the expression of ROS and VEGF and acts through RAGE to promote endothelial cell proliferation. Breast Cancer Res Treat 2012; 134: 71-80.
33. Shaorong Z, Xiaodong L, Qiong P, et al. SNHG12/NFYC-AS1 acted as the sponge for hsa-miR-199a-5p to promote the expression of S100A8/S100A7/XDH and was involved in the progression of diabetic foot ulcers. Mol Biotechnol 2023; 65: 2038-48.
34. Yoshioka M, Sawada Y, Saito-Sasaki N, et al. High S100A2 expression in keratinocytes in patients with drug eruption. Sci Rep 2021; 11: 5493.
35. Jin L, Wang G. Keratin 17: a critical player in the pathogene­sis of psoriasis. Med Res Rev 2014; 34: 438-54.
36. Mommers JM, van Rossum MM, van Erp PE, et al. Changes in keratin 6 and keratin 10 (co-)expression in lesional and symptomless skin of spreading psoriasis. Dermatology 2000; 201: 15-20.
37. Jiang S, Hinchliffe TE, Wu T. Biomarkers of an autoimmune skin disease--psoriasis. Genom Proteom Bioinformatics 2015; 13: 224-33.
38. Zhang W, Dang E, Shi X, et al. The pro-inflammatory cytokine IL-22 up-regulates keratin 17 expression in keratinocytes via STAT3 and ERK1/2. PLoS One 2012; 7: e40797.
39. Shi X, Jin L, Dang E, et al. IL-17A upregulates keratin 17 expression in keratinocytes through STAT1- and STAT3-dependent mechanisms. J Invest Dermatol 2011; 131: 2401-8.
40. Chang T, Sun L, Wang Y, et al. Inhibition of keratin 17 expression with antisense and RNAi strategies: exploring novel therapy for psoriasis. Exp Dermatol 2011; 20: 555-60.
41. Nelson AM, Reddy SK, Ratliff TS, et al. dsRNA released by tissue damage activates TLR3 to drive skin regeneration. Cell Stem Cell 2015; 17: 139-51.
42. Komine M, Rao LS, Freedberg IM, et al. Interleukin-1 induces transcription of keratin K6 in human epidermal keratinocytes. J Invest Dermatol 2001; 116: 330-8.
43. Ma S, Rao L, Freedberg IM, et al. Transcriptional control of K5, K6, K14, and K17 keratin genes by AP-1 and NF-kappaB family members. Gene Exp 1997; 6: 361-70.
Copyright: © 2026 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

Quick links
© 2026 Termedia Sp. z o.o.
Developed by Termedia.